activ
essenti
structur
polyprotein
process
play
key
role
viru
life
cycl
chikv
emerg
arthropodborn
pathogen
viru
public
health
concern
worldwid
vaccin
specif
antivir
treatment
current
avail
chikungunya
diseas
thu
import
develop
inhibitor
chikv
enzym
block
key
step
viral
reproduct
view
cvcp
produc
recombinantli
purifi
homogen
fluoresc
reson
energi
transfer
fret
base
proteolyt
assay
develop
high
throughput
screen
ht
fret
peptid
substrat
dabcylgaeewslaieedan
deriv
cleavag
site
present
structur
polyprotein
cvcp
use
assay
z
factor
coeffici
variat
cv
adapt
high
throughput
format
autom
screen
chemic
librari
identifi
cvcp
specif
proteas
inhibitor
kinet
paramet
k
k
cat
k
estim
use
fret
assay
sec
respect
avail
activ
recombin
cvcp
cost
effect
fluorogen
peptid
base
vitro
fret
assay
may
serv
basi
therapeut
develop
chikv
concentr
observ
cvcp
activ
result
provid
standard
condit
transproteolyt
activ
assay
cvcp
could
adopt
ht
cvcp
inhibitor
purif
activ
inact
cvcp
autoproteolysi
releas
cp
structur
polyprotein
remain
bound
near
activ
site
make
protein
inact
either
ci
tran
proteolyt
action
howev
previou
studi
alphaviru
cp
indic
activ
cp
restor
remov
conserv
ctermin
tryptophan
residu
order
evalu
enzymat
activ
cvcp
inact
activ
protein
express
purifi
firstli
proteas
domain
cvcp
clone
vector
form
express
plasmid
inact
protein
contain
full
proteas
domain
residu
truncat
last
two
residu
includ
ctermin
inact
construct
result
gener
activ
form
cvcp
residu
optim
express
condit
done
protein
get
good
amount
solubl
protein
optim
induct
temperatur
induct
time
iptg
concentr
protein
tag
nterminu
express
solubl
form
solubl
protein
purifi
imac
immobil
metal
assist
chromatographi
size
exclus
chromatographi
ninta
column
chromatographi
protein
elut
increas
concentr
imidazol
singl
band
observ
sdspage
purifi
protein
confirm
protein
homogen
fig
protein
band
visibl
kda
sdspage
also
confirm
gel
filtrat
chromatographi
compar
calcul
molecular
weight
use
standard
molecular
weight
marker
thu
confirm
activ
inact
cvcp
exist
monom
solut
vitro
transproteas
assay
cvcp
highli
sensit
fret
base
assay
use
determin
transproteolyt
activ
cvcp
vitro
transproteas
activ
cvcp
monitor
use
peptid
substrat
contain
benzoic
acid
dabcyl
amino
acid
edan
nand
cterminu
peptid
respect
pair
demonstr
fret
edan
act
fluorophor
dabcyl
quencher
quench
fluoresc
produc
edan
presenc
proteas
peptid
get
cleav
separ
two
fragment
reduc
fret
signal
activ
cvcp
exhibit
effici
cleavag
substrat
peptid
separ
edan
fluorophor
dabcyl
quencher
result
increas
fluoresc
signal
fluoresc
quench
proteolyt
cleavag
due
presenc
dabcyl
within
particular
distanc
rang
fluorophor
edan
fig
proteolyt
reaction
carri
mm
hepe
buffer
ph
cuvett
ml
reaction
volum
well
plate
l
reaction
volum
substrat
ad
start
reaction
fluoresc
enhanc
record
time
fig
rel
fluoresc
unit
calcul
read
figur
show
typic
fluoresc
profil
hydrolysi
substrat
control
reaction
also
perform
use
reaction
without
enzym
show
chang
fluoresc
intens
data
shown
determin
kinet
paramet
calcul
kinet
paramet
vi
enzym
differ
substrat
concentr
determin
fig
valu
normal
subtract
read
obtain
reaction
enzym
fluoresc
extinct
coeffici
fec
calcul
fret
substrat
fec
valu
use
determin
amount
product
format
reaction
kinet
paramet
k
k
cat
k
calcul
sec
respect
fig
inact
cvcp
use
neg
control
proteolyt
activ
assay
expect
show
insignific
increas
fluoresc
signal
data
shown
assay
valid
statist
determin
z
factor
coeffici
variat
cv
z
factor
use
assess
effici
ht
assay
defin
degre
separ
mean
valu
posit
control
mean
valu
background
signal
z
factor
valu
greater
consid
indic
authent
verit
screen
assay
cv
less
repres
less
variat
within
group
posit
neg
control
z
factor
cvcp
calcul
use
fret
peptid
substrat
confirm
high
sensit
effici
assay
scatter
plot
distribut
group
read
posit
neg
control
shown
fig
valu
z
factor
suggest
high
qualiti
assay
high
signal
nois
ratio
degre
variabl
posit
control
group
z
factor
cv
reveal
reliabl
present
fret
base
assay
ht
inhibitor
cvcp
inhibitor
screen
assay
cterminu
remain
bound
specif
pocket
inact
protein
ci
autoproteolysi
make
cvcp
inact
proteolyt
action
consid
screen
compound
peptid
tryptophan
tryptamin
ew
ew
serin
proteas
inhibitor
phenylmethanesulfonyl
fluorid
pmsf
benzamidin
nptosyllphenylalanin
chloromethyl
keton
tpck
inhibit
cvcp
activ
calcul
cleav
product
form
comparison
made
reaction
without
compound
cvcp
found
resist
tryptophanbas
compound
peptid
serin
proteas
inhibitor
complet
resist
tryptophan
tryptamin
ew
peptid
pmsf
even
high
concentr
howev
peptid
ew
could
show
lineweaverburk
plot
form
intercept
slope
calcul
accord
equat
mx
c
valu
v
max
k
determin
k
cat
also
calcul
divid
v
max
enzym
concentr
reduct
activ
cvcp
concentr
proteas
inhibitor
benzamidin
tpck
also
show
less
decreas
enzym
activ
concentr
thu
compound
peptid
test
show
signific
inhibitori
activ
cvcp
proteolyt
inhibitori
assay
test
use
tpck
chymotrypsin
posit
control
tpck
show
expect
inhibitori
activ
chymotrypsin
inhibit
constant
ki
effect
ph
nacl
enzymat
activ
cvcp
character
cvcp
activ
examin
ph
profil
enzym
activ
effect
differ
buffer
differ
ph
valu
observ
cvcp
activ
vi
calcul
differ
ph
plot
buffer
ph
graph
show
regular
pattern
enzymat
reaction
optimum
ph
fig
thu
optim
ph
transproteolyt
activ
cvcp
near
physiolog
ph
mimic
intracellular
environ
insid
mammalian
cell
undergo
cisproteolyt
cleavag
furthermor
titrat
experi
nacl
demonstr
effect
increas
salt
concentr
cvcp
activ
influenc
nacl
concentr
activ
studi
use
differ
nacl
concentr
mm
assay
buffer
increas
enzymat
activ
observ
nacl
concentr
afterward
gradual
decreas
activ
observ
enzym
show
maximum
activ
mm
nacl
concentr
fig
result
indic
ionic
strength
depend
variat
cvcp
activ
influenc
glycerol
enzym
activ
effect
antichaotrop
agent
glycerol
enzym
activ
also
observ
cvcp
found
suscept
inhibit
increas
glycerol
concentr
differ
concentr
glycerol
vv
use
reaction
veloc
measur
glycerol
neglig
increas
activ
found
howev
slight
increas
notic
concentr
glycerol
howev
increas
glycerol
concentr
result
decreas
enzymat
activ
glycerol
concentr
almost
activ
detect
fig
result
indic
glycerol
use
reaction
buffer
afterward
inhibit
catalyt
activ
enzym
use
buffer
ph
rang
ph
optimum
calcul
proteolyt
activ
rel
activ
calcul
differ
ph
take
activ
ph
b
activ
nacl
concentr
mm
taken
rel
activ
nacl
concentr
calcul
read
averag
triplic
data
valu
normal
use
read
obtain
reaction
contain
enzym
scientif
report
doi
discuss
chikungunya
case
increas
drastic
last
year
result
ravag
outbreak
less
number
studi
perform
till
date
aim
antivir
develop
chikv
noninfecti
chikv
replicon
report
gene
cell
base
phenotyp
assay
inhibitor
chikv
also
open
possibl
antivir
screen
howev
follow
studi
miss
also
lack
vitro
assay
antivir
screen
studi
promot
us
toward
detail
understand
develop
newer
method
antichikv
compound
screen
antivir
drug
develop
last
decad
howev
virus
evolv
rapidli
emerg
differ
area
lack
effect
therapi
import
virus
reemerg
chikv
epidem
number
differ
region
addit
mosquito
vector
due
evolut
viru
mutat
glycoprotein
pathogen
viru
includ
persist
arthralgia
make
signific
pathogen
need
proper
attent
henc
necess
antichikv
drug
develop
effici
therapeut
protocol
manifest
though
mortal
rate
chikungunya
infect
high
high
evolut
rate
genom
chikv
encourag
us
develop
new
promis
antivir
therapeut
chikv
experi
show
presenc
cvcp
monom
activ
inact
cvcp
solut
also
describ
avcp
confirm
alphaviru
cp
show
tran
proteolyt
activ
monomer
form
capsid
proteas
repres
signific
target
antichikv
drug
develop
involv
first
step
structur
polyprotein
process
fluorogen
substrat
use
high
throughput
compound
screen
number
viral
proteas
sar
coronaviru
proteas
west
nile
viru
serin
proteas
hiv
human
immunodefici
viru
proteas
dengu
proteas
hcv
hepat
c
viru
proteas
effect
increas
glycerol
concentr
reaction
buffer
enzymat
activ
cvcp
observ
rel
activ
measur
take
activ
glycerol
graph
repres
averag
data
obtain
three
experi
b
cvcp
homolog
model
magenta
glycerol
specif
pocket
gener
superimpos
crystal
structur
avcp
bound
p
residu
green
pdb
id
overal
structur
show
presenc
two
subdomain
activ
site
present
interfac
two
subdomain
activ
site
residu
shown
stick
specif
pocket
present
vicin
activ
site
shown
circl
p
residu
nativ
avcp
bind
c
zoomin
surfac
view
pocket
show
glycerol
blue
cvcp
structur
bind
incis
posit
conserv
p
residu
trp
red
bind
avcp
activ
site
shown
blue
color
scientif
report
doi
techniqu
simpl
highli
sensit
henc
provid
tool
ht
antivir
moreov
vitro
assay
conveni
need
contain
current
studi
focus
transproteolyt
activ
assay
cvcp
use
fret
base
fluorogen
peptid
substrat
continu
fluoresc
assay
continu
increas
rel
fluoresc
unit
time
time
depend
fluoresc
enhanc
reveal
truncat
purifi
cvcp
tran
catalyt
activ
kinet
studi
assay
perform
increas
concentr
substrat
increas
veloc
occur
increas
substrat
concentr
get
satur
kinet
paramet
activ
cvcp
found
k
k
cat
k
sec
fret
base
proteolyt
assay
also
check
use
high
throughput
format
screen
compound
cvcp
gener
assess
assay
qualiti
reliabl
z
factor
coeffici
variat
determin
well
plate
found
respect
demonstr
valu
z
factor
cv
studi
fret
base
vitro
proteolyt
assay
cvcp
highli
conveni
suitabl
ht
compound
assay
might
provid
perfect
approach
explor
first
gener
cvcp
inhibitor
use
fluoresc
plate
reader
assay
easili
perform
plate
format
high
throughput
inhibitor
screen
cvcp
high
throughput
proteas
assay
simpl
conveni
cost
effect
compound
screen
inhibit
cvcp
activ
tryptophan
tryptamin
compound
peptid
ew
ew
could
inhibit
cvcp
activ
addit
differ
serin
proteas
inhibitor
pmsf
benzamidin
tpck
also
seem
act
potent
inhibitor
cvcp
consist
previou
report
cisautoproteolyt
activ
cvcp
transesteras
activ
sfcp
complet
resist
standard
serin
proteas
inhibitor
observ
cisautoproteolyt
activ
cvcp
inhibit
serin
proteas
inhibitor
aebsf
benzen
sulfonyl
fluorid
hydrochlorid
addit
tran
esteras
activ
sfcp
show
inhibit
presenc
proteas
inhibitor
pmsf
chloromethylketon
nbenzyloxycarbonylleucinetyrosinechloromethylketon
nbenzyloxycarbonylphenylalaninechloromethylketon
nacetylglutamateglutamatetryptophan
pnitroanilid
henc
possibl
substrat
specif
pocket
cvcp
distinct
conform
seen
crystal
structur
activ
avcp
pdb
id
obtrud
block
posit
influenc
variou
condit
proteolyt
activ
activ
cvcp
also
determin
respect
ph
rang
differ
nacl
glycerol
concentr
use
measur
activ
rel
activ
calcul
optimum
enzym
activ
found
ph
mm
nacl
concentr
optimum
ph
neutral
ph
correspond
ph
mosquito
saliva
human
cell
thu
optim
activ
occur
physiolog
ph
match
host
cell
ph
effect
ph
enzym
activ
might
due
conform
variat
enzym
structur
differ
ph
addit
respons
enzymat
activ
increas
ionic
strength
indic
depend
proteas
structur
salt
concentr
signific
increas
enzymat
activ
mm
nacl
concentr
might
due
stabil
enzym
increas
ionic
strength
howev
decreas
activ
mm
nacl
might
result
alter
molecular
interact
activ
site
specif
pocket
high
nacl
concentr
increas
ionic
strength
might
disrupt
ionic
polar
interact
structur
cvcp
lead
conform
chang
activ
site
antichaotrop
agent
glycerol
also
affect
enzym
function
glycerol
ad
reaction
buffer
cvcp
proteas
assay
reaction
gener
glycerol
act
stabil
agent
protein
expect
reduc
enzymat
activ
interestingli
concentr
glycerol
reaction
buffer
complet
loss
cvcp
enzymat
activ
might
due
bind
glycerol
molecul
specif
pocket
cvcp
could
block
entri
substrat
insid
pocket
thu
inhibit
catalyt
reaction
explor
possibl
three
dimension
structur
activ
cvcp
predict
homolog
model
base
crystal
structur
activ
avcp
pdb
id
cvcp
molecular
model
consist
chymotrypsinlik
serin
proteas
fold
two
subdomain
activ
site
locat
interfac
subdomain
fig
cvcp
activ
site
contribut
residu
specif
pocket
present
near
activ
site
conserv
p
substrat
residu
expect
bind
furthermor
superimposit
homolog
model
activ
cvcp
complex
glycerol
onto
nativ
avcp
inact
avcp
pdb
id
rmsd
show
interact
glycerol
molecul
exactli
posit
conserv
p
tryptophan
residu
bind
specif
pocket
fig
specif
pocket
cvcp
includ
residu
residu
creat
hydrophob
environ
bind
substrat
glycerol
molecul
fit
perfectli
insid
hydrophob
pocket
activ
cvcp
structur
hydroxyl
group
glycerol
molecul
show
interact
backbon
also
activ
site
residu
crystal
structur
activ
avcp
pdb
id
glycerol
use
cryoprotect
data
collect
assum
stabil
protein
bind
pocket
henc
conclud
activ
assay
result
coupl
structur
comparison
analysi
high
concentr
glycerol
might
compet
substrat
peptid
bind
specif
pocket
cvcp
infer
monomer
form
truncat
cvcp
transproteolyt
activ
describ
fret
base
assay
use
ht
compound
cvcp
high
throughput
screen
small
molecul
compound
librari
cvcp
next
essenti
step
identif
potenti
cvcp
inhibitor
like
inhibit
first
step
structur
polyprotein
process
thu
compound
interf
proteolyt
activ
cvcp
might
potenti
candid
drug
chikv
infect
henc
studi
make
transproteas
activ
assay
cvcp
avail
provid
channel
ht
compound
librari
alphaviru
capsid
proteas
benefici
combat
emerg
pathogen
chikungunya
viru
prepar
chikv
stock
indian
isol
chikungunya
viru
genbank
access
belong
east
central
south
african
ecsa
genotyp
maintain
virolog
divis
drde
gwalior
use
present
studi
cell
aed
albopictu
larval
cell
line
obtain
nation
center
cell
scienc
ncc
pune
cell
cultur
eagl
minimum
essenti
medium
emem
supplement
tryptos
phosphat
broth
tpb
fetal
bovin
serum
fb
u
gentamicin
mm
lglutamin
gl
sodium
bicarbon
nahco
briefli
monolay
cell
grown
confluenc
wash
plain
medium
prior
infect
viru
allow
adsorb
cell
h
serumfre
medium
follow
adsorpt
inoculum
remov
wash
dulbecco
phosphatebuff
salin
dpb
replenish
mainten
medium
ememtpb
fb
cultur
medium
harvest
appear
cytopath
effect
h
post
infect
aliquot
store
freezer
rna
extract
viral
rna
isol
l
clarifi
infect
cultur
supernat
use
qiaamp
viral
rna
mini
kit
qiagen
germani
accord
manufactur
protocol
viral
rna
quantifi
aliquot
store
use
molecular
clone
construct
express
plasmid
obtain
rna
denatur
min
chill
ice
first
strand
cdna
synthes
use
oligo
dt
primer
mmulv
revers
transcriptas
h
primer
recombin
dna
clone
design
accord
sequenc
provid
ncbi
nation
center
biotechnolog
inform
tabl
chikv
dna
fragment
kbp
encod
structur
polyprotein
amplifi
use
synthes
cdna
templat
oligonucleotid
use
amplif
structur
polyprotein
amplifi
product
subject
polymeras
chain
reaction
pcr
primer
ndei
bamhi
restrict
enzym
site
pcr
product
purifi
use
pcr
purif
kit
qiagen
restrict
digest
purifi
pcr
product
done
vector
digest
use
ndei
bamhi
restrict
enzym
digest
product
subject
agaros
gel
electrophoresi
digest
band
excis
dna
elut
excis
band
agaros
gel
use
dna
gel
extract
kit
qiagen
usa
two
dna
fragment
ligat
overnight
dna
ligas
ligat
mixtur
transform
e
coli
cell
cultur
spread
luria
bertani
lb
agar
plate
gml
kanamycin
plate
incub
overnight
coloni
pick
screen
presenc
structur
polyprotein
encod
gene
insert
confirm
construct
contain
gene
encod
structur
polyprotein
chikv
use
templat
amplif
inact
cvcp
residu
activ
ctermin
truncat
cvcp
residu
amplif
cvcp
carri
use
oligonucleotid
inact
cvcp
activ
cvcp
ndei
xhoi
site
use
protocol
describ
pcr
amplifi
product
subclon
vector
contain
tobacco
etch
viru
tev
proteas
cleavag
site
instead
thrombin
posit
clone
contain
insert
identifi
pcr
restrict
enzym
digest
isol
plasmid
dna
sequenc
isol
plasmid
done
confirm
presenc
gene
fragment
encod
inact
activ
cvcp
ntermin
tobacco
etch
viru
tev
proteas
cleavabl
tag
incorpor
construct
facilit
protein
purif
use
ni
affin
chromatographi
cvcp
carri
produc
protein
solubl
form
plasmid
construct
transform
e
coli
strain
rossetta
plate
lb
agar
plate
contain
kanamycin
gml
chloramphenicol
gml
plate
incub
overnight
singl
coloni
pick
grown
overnight
lb
broth
supplement
appropri
antibiot
construct
use
inoculum
overnight
primari
cultur
secondari
cultur
grown
l
conic
flask
inact
cvcp
secondari
cultur
grown
till
od
nm
od
reach
afterward
protein
express
induc
use
mm
isopropyl
iptg
induct
cultur
grown
h
express
activ
cvcp
secondari
cultur
grown
till
od
reach
cultur
transfer
express
activ
cvcp
induc
use
mm
iptg
od
induct
cultur
grown
h
cell
harvest
centrifug
analyz
sdspage
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
confirm
protein
express
solubl
purif
activ
inact
cvcp
purif
protein
done
use
cell
pellet
cultur
pellet
resuspend
ml
bind
buffer
mm
trishcl
ph
mm
imidazol
mm
nacl
ice
resuspend
cell
disrupt
use
cell
disruptor
constant
system
ltd
daventri
england
centrifug
g
separ
supernat
pellet
ninta
nitrilotriacet
acid
agaros
bead
qiagen
usa
preequilibr
bind
buffer
load
clarifi
supernat
incub
done
half
hour
ntermin
histag
protein
elut
use
mm
imidazol
pure
protein
fraction
elut
affin
chromatographi
column
pool
histag
cleav
overnight
incub
purifi
protein
tev
proteas
dialysi
dialysi
buffer
mm
trishcl
ph
mm
nacl
cleavag
histag
protein
sampl
reload
onto
ninta
column
remov
histag
tev
proteas
uncleav
histag
protein
flowthrough
contain
purifi
protein
without
histag
concentr
mgml
use
kda
cutoff
amicon
concentr
millipor
bedford
massachusett
usa
concentr
protein
load
onto
hiload
superdex
pg
sizeexclus
chromatographi
column
ge
healthcar
use
mm
trishcl
ph
mm
nacl
buffer
filter
degass
purifi
ge
healthcar
purif
system
kept
oper
flow
rate
mlmin
use
conduct
gelfiltr
chromatographi
step
fraction
major
peak
collect
analyz
use
sdspage
gelfiltr
fraction
contain
protein
interest
pool
concentr
mgml
molecular
weight
marker
protein
bovin
serum
albumin
kda
ovalbumin
kda
trypsin
kda
lysozym
kda
load
run
sizeexclus
hiload
superdex
column
determin
void
volum
column
construct
standard
curv
standard
curv
use
estim
molecular
weight
purifi
protein
uv
absorb
spectroscopi
wavelength
nm
use
extinct
coeffici
cm
inact
cvcp
cm
activ
cvcp
use
estim
concentr
protein
transproteolyt
activ
cvcp
custom
synthes
peptid
dabcylgaeewslaieedan
use
substrat
biolinkk
new
delhi
india
substrat
peptid
consist
nine
amino
acid
deriv
p
p
posit
cleavag
site
cvcp
number
assign
substrat
residu
p
p
posit
includ
residu
scissil
bond
residu
enumer
toward
amino
carboxyl
terminu
respect
fig
vitro
transproteolyt
activ
assay
transproteas
activ
cvcp
measur
substrat
fluoresc
intens
linearli
proport
concentr
fluoresc
peptid
substrat
reaction
volum
l
use
conduct
micropl
assay
plate
assay
excit
emiss
wavelength
fluorogen
peptid
substrat
associ
bandwidth
filter
dabcyl
nm
edan
nm
chymotrypsin
use
posit
control
fret
assay
cvcp
fec
use
determin
amount
product
format
time
determin
fec
certain
instrument
set
assay
condit
reaction
carri
assay
buffer
mm
hepe
ph
use
vari
concentr
substrat
use
excess
cvcp
use
excess
enzym
ensur
rapid
complet
cleavag
substrat
curv
rel
fluoresc
unit
rfu
fluoresc
reaction
minu
fluoresc
obtain
reaction
absenc
enzym
vari
substrat
concentr
plot
slope
curv
calcul
assign
fec
substrat
peptid
determin
reaction
rate
turn
number
initi
reaction
rate
calcul
perform
abovedescrib
reaction
triplic
rate
determin
monitor
chang
rfu
time
rfu
convert
concentr
product
form
use
fec
reaction
also
carri
use
protocol
enzym
determin
baselin
proteolysi
rate
initi
veloc
differ
time
point
calcul
plot
vari
substrat
concentr
determin
kinet
paramet
includ
v
max
k
k
cat
k
valu
turn
number
calcul
use
concentr
capsid
proteas
enzym
use
z
factor
use
evalu
qualiti
ht
assay
z
factor
calcul
accord
method
describ
zhang
et
al
determin
use
fret
substrat
describ
substrat
ad
assay
buffer
contain
capsid
proteas
enzym
assay
buffer
without
enzym
fluoresc
read
measur
posit
neg
control
calcul
standard
deviat
mean
coeffici
z
factor
obtain
valu
defin
p
n
p
n
standard
deviat
averag
posit
p
neg
n
control
respect
cv
calcul
ratio
standard
deviat
averag
sampl
read
valu
express
percentag
multipli
ratio
cvcp
inhibit
assay
inhibitori
activ
variou
commerci
avail
serin
proteas
inhibitor
pmsf
benzamidin
tpck
tryptophan
tryptamin
deriv
tryptophan
substratederiv
peptid
ew
ew
test
cvcp
proteas
compound
purchas
sigmaaldrich
st
loui
mo
custom
synthes
peptid
procur
biolinkk
pvt
ltd
delhi
stock
solut
mm
made
dmso
requir
final
concentr
inhibitor
made
dilut
assay
buffer
concentr
dmso
final
reaction
exceed
vv
substrat
use
final
concentr
minim
inner
filter
effect
produc
strong
signal
activ
cvcp
preincub
compound
min
follow
addit
substrat
peptid
concentr
compound
use
final
assay
volum
l
enzym
reaction
perform
half
area
black
flat
bottom
plate
corn
life
scienc
fluoresc
read
taken
differ
time
point
min
amount
cleav
product
calcul
describ
compar
control
reaction
well
without
inhibitor
format
cleav
product
get
reduc
presenc
potenti
inhibitor
cvcp
tpck
known
chymotrypsin
inhibitor
chymotrypsin
use
posit
control
enzymat
inhibit
assay
influenc
ph
nacl
glycerol
effect
ph
enzymat
activ
observ
use
differ
buffer
ph
rang
buffer
use
optim
ph
rang
mm
sodium
acet
ph
me
ph
hepe
ph
trishcl
ph
bicin
ph
glycinenaoh
ph
influenc
vari
concentr
nacl
glycerol
proteolyt
activ
cvcp
analyz
perform
reaction
vari
concentr
nacl
glycerol
vv
initi
veloc
enzym
calcul
differ
condit
rel
activ
measur
experi
determin
optim
assay
condit
cvcp
activ
perform
triplic
scientif
report
doi
model
gener
homolog
model
perform
activ
cvcp
follow
step
templat
select
protein
data
bank
pdb
b
sequenc
templat
align
c
model
build
refin
valid
ncbi
blast
search
tool
use
perform
templat
search
crystal
structur
avcp
pdb
id
select
templat
sequenc
ident
cvcp
clustal
omega
program
use
multipl
sequenc
align
queri
sequenc
templat
sequenc
http
wwwebiacuktoolsmsaclustalo
align
use
build
pir
format
align
file
input
model
model
ligand
glycerol
gol
incorpor
pir
format
gener
homolog
model
model
built
gave
c
alpha
rootmeansquar
deviat
rmsd
observ
structur
sever
model
gener
model
lowest
dope
score
evalu
use
procheck
errat
http
nih
servermbiuclaedusav
model
least
number
residu
disallow
region
evalu
energi
minim
use
swisspdb
viewer
http
spdbvvitalitch
